AI assistant
Jazz Pharmaceuticals plc — Director's Dealing 2010
Aug 27, 2010
30751_dirs_2010-08-27_d24bfd80-53f9-4fb7-9691-4a7f0358a71f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-08-25
Reporting Person: MOMTAZEE JAMES C (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-08-25 | Phantom Stock | $ | A | 3045 | Acquired | Common Stock (3045) | Direct | |
| 2010-08-25 | Director Stock Option (Right to Buy) | $8.23 | A | 12500 | Acquired | 2020-08-25 | Common Stock (12500) | Direct |
Footnotes
F1: Each share of phantom stock is the amount equivalent to one share of the Issuer's common stock.
F2: The shares of phantom stock become payable in common stock upon the earlier to occur of the tenth business day following (i) the Reporting Person's separation from service as a director or (ii) a Change of Control of the Issuer (as defined under the Issuer's Directors Deferred Compensation Plan, as amended).
F3: The option shares shall vest in a series of twelve (12) successive equal installments upon completion of each month of Continuous Service (as defined under the Issuer's 2007 Non-Employee Directors Stock Option Plan, as amended) over the one (1)-year period measured from August 15, 2010.